A three-member panel of the Fourth Circuit Court of Appeals has allowed the U.S. military to reinstate its enlistment ban for ...

Investigators at the University of Alabama at Birmingham led a study from the ACTG, an NIH-funded global clinical trials network focused on HIV and other infectious diseases, to target the challenges ...

According to South Africa’s Department of Health, discussions will focus on reviewing progress against existing regional health commitments and coordinating stronger responses to shared public health ...

The running themes of treating and preventing HIV will be highlighted early in the plenary session held on Monday morning.

Zimbabwe is one of the first countries to introduce the HIV prevention drug lenacapavir. The program aims to target over 46,000 high-risk individuals, backed by U.S. funding and the Global Fund.

Uganda's move to integrate HIV services into general outpatient departments (OPDs) is being hailed as a step toward more efficient health care--but it also raises questions about patient rights, ...

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African ...

It has taken about two decades, but the world finally has a new, longer-acting injectable drug for HIV prevention. Yesterday, Kenya received 21,000 doses of Lenacapavir, also known as LEN, with about ...